“Ocular hypotensive efficacy of a new liposomal latanoprost formulation administered by different routes for experimental ocular hypertension” (2025) Ukrainian Journal of Ophthalmology , (2), pp. 37–41. doi:10.31288/oftalmolzh202223741.